Collegium Pharmaceutical Inc. (NASDAQ: COLL) stock closed at 18.3 per share at the end of the most recent trading day (a 6.03% change compared to the prior day closing price) with a volume of 766.15K shares and market capitalization of 621.71M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 234 people. Collegium Pharmaceutical Inc. CEO is Joseph J. Ciaffoni.

The one-year performance of Collegium Pharmaceutical Inc. stock is -28.53%, while year-to-date (YTD) performance is -2.03%. COLL stock has a five-year performance of 42.52%. Its 52-week range is between 14.04 and 25.66, which gives COLL stock a 52-week price range ratio of 36.66%

Collegium Pharmaceutical Inc. currently has a PE ratio of 14.90, a price-to-book (PB) ratio of 2.74, a price-to-sale (PS) ratio of 1.97, a price to cashflow ratio of 10.80, a PEG ratio of 2.32, a ROA of 4.61%, a ROC of 7.71% and a ROE of 23.99%. The company’s profit margin is 14.92%, its EBITDA margin is 21.20%, and its revenue ttm is $272.90 Million , which makes it $8.03 revenue per share.

Of the last four earnings reports from Collegium Pharmaceutical Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $1.26 for the next earnings report. Collegium Pharmaceutical Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Collegium Pharmaceutical Inc. is Moderate Buy (1.63), with a target price of $27.71, which is +51.42% compared to the current price. The earnings rating for Collegium Pharmaceutical Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Collegium Pharmaceutical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Collegium Pharmaceutical Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 12.07, ATR14 : 0.75, CCI20 : 284.08, Chaikin Money Flow : 0.21, MACD : 0.26, Money Flow Index : 82.30, ROC : 14.66, RSI : 68.94, STOCH (14,3) : 99.69, STOCH RSI : 1.00, UO : 63.13, Williams %R : -0.31), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Collegium Pharmaceutical Inc. in the last 12-months were: Joseph Ciaffoni (Sold 76 094 shares of value $1 405 223 ), Scott Dreyer (Sold 10 559 shares of value $228 180 )